home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Collection of Education
/
collectionofeducationcarat1997.iso
/
HEALTH
/
MED9605D.ZIP
/
M9650936.TXT
< prev
next >
Wrap
Text File
|
1996-03-30
|
2KB
|
34 lines
Document 0936
DOCN M9650936
TI [Gene therapy for AIDS: current trends]
DT 9505
AU Takatsuki K; Obaru K; Yoshimura K; Matsushita S; Second Department of
Internal Medicine, Kumamoto University; School of Medicine.
SO Nippon Rinsho. 1996 Jan;54(1):233-41. Unique Identifier : AIDSLINE
MED/96155336
AB Genetic manipulation of somatic cells may be of therapeutic value in a
variety of infectious diseases, particularly in human immunodeficiency
virus (HIV) infection. Stable insertion of resistance genes into cells,
susceptible to HIV, could reduce the viral burden in infected
individuals and potentially retard the characteristic progressive immune
dysfunction. Alternatively, ectopic expression of genes that encode
viral antigens, might induce potent antiviral immune responses and form
the basis for novel prophylactic and therapeutic vaccines. While
laboratory studies have proved that the approach works in principle,
preclinical and clinical studies will be necessary to evaluate the
therapeutic benefits of such gene-based therapies. Currently, more than
400 patients have already been treated by this innovative therapeutic
strategy in the US. In Japan, the Expert Committee on Gene therapy was
set up in the council on Science and the Public Health and Welfare in
1991. Recently, gene therapy for ADA has been approved. It is thought
that the first gene therapy against HIV infection in Japan is not far
away.
DE Acquired Immunodeficiency Syndrome/*THERAPY Animal English Abstract
Gene Therapy/*TRENDS Gene Transfer Genetic Vectors Human
HIV-1/*GENETICS/IMMUNOLOGY Mutation RNA, Catalytic RNA, Viral
JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).